PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1501.77%
Revenue growth above 1.5x FSLR's 70.56%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
1407.19%
Gross profit growth above 1.5x FSLR's 27.48%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
172.69%
EBIT growth above 1.5x FSLR's 35.94%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
28.26%
Operating income growth at 50-75% of FSLR's 41.85%. Martin Whitman would doubt the firm’s ability to compete efficiently.
160.27%
Net income growth above 1.5x FSLR's 25.61%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
160.19%
EPS growth above 1.5x FSLR's 25.68%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
160.19%
Diluted EPS growth above 1.5x FSLR's 25.43%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-18.99%
Negative OCF growth while FSLR is at 1609.28%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-18.62%
Negative FCF growth while FSLR is at 202.01%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-86.72%
Negative 10Y revenue/share CAGR while FSLR stands at 40.65%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-70.29%
Negative 5Y CAGR while FSLR stands at 6.54%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-47.05%
Negative 3Y CAGR while FSLR stands at 65.73%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-136.42%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-2146.53%
Negative 5Y OCF/share CAGR while FSLR is at 2.17%. Joel Greenblatt would question the firm’s operational model or cost structure.
-2333.49%
Negative 3Y OCF/share CAGR while FSLR stands at 2236.90%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-39.18%
Negative 10Y net income/share CAGR while FSLR is at 91.76%. Joel Greenblatt sees a major red flag in long-term profit erosion.
1647.18%
5Y net income/share CAGR above 1.5x FSLR's 751.63%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
434.26%
3Y net income/share CAGR above 1.5x FSLR's 197.20%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
-111.09%
Negative equity/share CAGR over 10 years while FSLR stands at 48.58%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-2041.68%
Negative 5Y equity/share growth while FSLR is at 54.13%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-157.67%
Negative 3Y equity/share growth while FSLR is at 32.95%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
511.98%
AR growth well above FSLR's 39.49%. Michael Burry fears inflated revenue or higher default risk in the near future.
3542.50%
We show growth while FSLR is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
33.84%
Asset growth above 1.5x FSLR's 6.01%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
31.65%
BV/share growth above 1.5x FSLR's 5.05%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-24.35%
We’re deleveraging while FSLR stands at 3.55%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
134.10%
SG&A growth well above FSLR's 7.10%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.